Wenn das alte News sind, dann sorry.
www.bernama.com/en/news.php?id=1992308
SEOUL, Aug. 13 -- South Korea said Friday it has signed a deal with U.S. pharmaceutical giant Pfizer Inc. to buy 30 million doses of COVID-19 vaccines to be
administered next year and has an option for an additional 30 million doses, health authorities said.
The contract is part of the Seoul government's plan to secure 50 million vaccine doses to cover the first shots of the country's population of 52 million for next year,
according to the Korea Disease Control and Prevention Agency (KDCA).
The supply of 30 million Pfizer doses will begin in the first quarter of next year, and another 30 million doses can be purchased when needed, Yonhap news agency
quoting KDCA as saying.
The KDCA said it will consider buying an additional 20 million doses for next year, aimed at battling the spread of COVID-19 variants, such as the delta strain.
The authorities said they will consider various factors, such as the latest study on efficacy against variants, in regard to the optional purchase of additional doses.
In June, the country began preparations to secure more vaccines for next year as the COVID-19 pandemic here is expected to continue even after achieving muchawaited
herd immunity this year.
Since the country launched its vaccination program in late February, a total of 21.98 million people, or 42.8 percent of the country's 51.34 million population, have
received their first shots.
Around 17.4 per cent, or 8.93 million people, have been fully vaccinated, according to the KDCA.
-- BERNAMA
Zurück
Weiter
